Chi-Med
Eli Lilly teams up with Chi-Med for Chinese sales of Elunate capsules
July 28, 2020Manufacturing and Production, Sales and Marketing Chi-Med, China, Eli Lilly
Eli Lilly Shanghai, an affiliate of the wider company, has enlisted the help of biopharma firm Hutchinson China MediTech, or …
AstraZeneca lung cancer drug proves able to shrink EGFR mutation-positive tumours
October 17, 2017Manufacturing and Production, Research and Development AstraZeneca, Cancer, Chi-Med, lung cancer, pharma, savolitinib
AstraZeneca and its partner Hutchison China MedTech, also known as Chi-Med, have announced positive data for savolitinib in combination with …
Chi-Med to get $10 million milestone from AstraZeneca after initiation of expanded Phase II trials in NSCLC
June 20, 2016Research and Development, Sales and Marketing AstraZeneca, Chi-Med, Iressa, Tagrisso, drug trial, lung cancer
Hutchison China MediTech (Nasdaq: HCM) on Monday said it is expanding Phase II trials in non-small cell lung cancer to …
Chi-Med starts Phase II trial for thyroid cancer drug
March 2, 2016Research and Development Chi-Med
Hutchison China MediTech (Chi-Med) says its unit Hutchison MediPharma (HMP) has initiated mid-stage trials for sulfatinib to treat differentiated thyroid …
Latest content
Long-acting therapies set to reshape HIV treatment market
August 21, 2026
MHRA approves Romvimza for tenosynovial giant cell tumour
August 20, 2026
